ESCAPE Bio, Inc. — Form D/A

ESCAPE Bio, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2018-10-11. The offering totals $63.0M, of which $63.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Markus Anne GoebelDirectorSouth San Francisco, CA
Judith Anne LiDirectorSouth San Francisco, CA
Judith LiDirectorSan Diego, CA
Leon ChenDirectorAustin, TX
Leon ChenExecutive OfficerAustin, TX
Peter ThompsonDirectorChanhassen, MN
Asish XavierDirectorSouth San Francisco, CA
Eric ShiozakiDirectorSan Francisco, CA
Peter MoldtDirectorSeattle, WA
Peter Anne MoldtDirectorSouth San Francisco, CA
Carrolee Sanders BarlowExecutive OfficerSouth San Francisco, CA
Paul Sanders WrenExecutive OfficerSouth San Francisco, CA
Asish Sanders XavierDirectorSouth San Francisco, CA
Laura Anne BrassDirectorSouth San Francisco, CA
Perry Anne KarsenDirectorSouth San Francisco, CA
Julie Anne SmithDirectorSouth San Francisco, CA
Julie Anne SmithExecutive OfficerSouth San Francisco, CA
R. Sanders WilliamsDirectorSouth San Francisco, CA
Peter Anne ThompsonDirectorSouth San Francisco, CA
Anthony Sanders RimacExecutive OfficerSouth San Francisco, CA
Asish Anne XavierDirectorSan Francisco, CA
Giovanni FerarraDirectorSan Francisco, CA
R Sanders WilliamsDirectorSan Francisco, CA
Giovanni FerraraDirectorSan Francisco, CA
R. Sanders WilliamsDirectorSan Francisco, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2020-09-28D$73.0M$73.0M
2019-07-29D$35.0M$31.1M
2017-06-02D/A$63.0M$46.0M
2015-08-31D$55.0M$20.0M

More